FI114011B - Suonensisäiseen käyttöön tarkoitetun immunoglobuliinin käyttö farmaseuttisen koostumuksen valmistamiseksi syöpäsairauksien hoitamiseksi - Google Patents
Suonensisäiseen käyttöön tarkoitetun immunoglobuliinin käyttö farmaseuttisen koostumuksen valmistamiseksi syöpäsairauksien hoitamiseksi Download PDFInfo
- Publication number
- FI114011B FI114011B FI963598A FI963598A FI114011B FI 114011 B FI114011 B FI 114011B FI 963598 A FI963598 A FI 963598A FI 963598 A FI963598 A FI 963598A FI 114011 B FI114011 B FI 114011B
- Authority
- FI
- Finland
- Prior art keywords
- ivig
- mice
- tumor
- preparation
- intravenous
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/54—F(ab')2
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21236194A | 1994-03-14 | 1994-03-14 | |
US21236194 | 1994-03-14 | ||
US08/340,094 US5562902A (en) | 1994-03-14 | 1994-11-15 | Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin |
US34009494 | 1994-11-15 | ||
PCT/US1995/002910 WO1995024927A1 (en) | 1994-03-14 | 1995-03-09 | Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins |
US9502910 | 1995-03-09 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI963598A0 FI963598A0 (fi) | 1996-09-12 |
FI963598A FI963598A (fi) | 1996-09-12 |
FI114011B true FI114011B (fi) | 2004-07-30 |
Family
ID=26907064
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI963598A FI114011B (fi) | 1994-03-14 | 1996-09-12 | Suonensisäiseen käyttöön tarkoitetun immunoglobuliinin käyttö farmaseuttisen koostumuksen valmistamiseksi syöpäsairauksien hoitamiseksi |
Country Status (20)
Country | Link |
---|---|
US (2) | US5562902A (xx) |
EP (1) | EP0750514B1 (xx) |
JP (2) | JP4004062B2 (xx) |
KR (1) | KR100352583B1 (xx) |
CN (1) | CN1089007C (xx) |
AT (1) | ATE198711T1 (xx) |
AU (1) | AU700751B2 (xx) |
BR (1) | BR9507067A (xx) |
CA (1) | CA2184269A1 (xx) |
DE (1) | DE69519924T2 (xx) |
DK (1) | DK0750514T3 (xx) |
ES (1) | ES2155519T3 (xx) |
FI (1) | FI114011B (xx) |
GR (1) | GR3035758T3 (xx) |
HK (1) | HK1014493A1 (xx) |
IL (1) | IL112963A (xx) |
NZ (1) | NZ282659A (xx) |
PT (1) | PT750514E (xx) |
TW (1) | TW418091B (xx) |
WO (1) | WO1995024927A1 (xx) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070166313A1 (en) * | 1994-03-14 | 2007-07-19 | Yehuda Shoenfeld | Administration of gamma globulins to treat cancer |
US20080050390A1 (en) * | 1994-03-14 | 2008-02-28 | Yehuda Shoenfeld | Administration of gamma globulins to treat metastatic melanoma |
WO1999057152A1 (en) | 1998-05-07 | 1999-11-11 | Research Corporation Technologies, Inc. | Oral administration of immunoglobulins for treating autoimmune hearing loss |
TWI248819B (en) * | 1999-09-27 | 2006-02-11 | Arp Biomed Ltd | Pharmaceutical composition containing IVIG for use in treating lymphoma |
EP1267905B1 (en) * | 2000-03-10 | 2005-09-28 | Medinnova As | Composition for the treatment of heart failure |
AT410637B (de) * | 2001-06-01 | 2003-06-25 | Igeneon Krebs Immuntherapie | Verwendung von polyklonalen immunglobulinen |
AU2002306251A1 (en) | 2002-02-15 | 2003-09-04 | Richard Brunner | 7s immunoglobulin for treatment of choroidal neovascularisation_ |
US20080031903A1 (en) * | 2006-07-27 | 2008-02-07 | Andrea Gambotto | Method of treating ocular infections |
WO2008137159A1 (en) * | 2007-05-07 | 2008-11-13 | Gammacan | Human anti-vegf polyclonal antibodies and uses thereof |
US20110311557A1 (en) * | 2009-02-11 | 2011-12-22 | Martin Heath Bluth | Reciprocal serum/plasma exchange for the treatment of cancer |
CN114129722B (zh) * | 2020-09-04 | 2024-04-05 | 中国医学科学院输血研究所 | 注射用人免疫球蛋白在制备预防或治疗辐照损伤的药物中的用途 |
CN114392351B (zh) * | 2021-07-13 | 2024-04-05 | 中国医学科学院放射医学研究所 | 毛螺菌科细菌与注射用人免疫球蛋白的联合用药物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4699783A (en) * | 1983-03-11 | 1987-10-13 | Terman David S | Products and methods for treatment of cancer |
US4834975A (en) * | 1984-05-25 | 1989-05-30 | Genetics Corporation | Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production |
US4699784A (en) * | 1986-02-25 | 1987-10-13 | Center For Molecular Medicine & Immunology | Tumoricidal methotrexate-antibody conjugate |
TWI248819B (en) * | 1999-09-27 | 2006-02-11 | Arp Biomed Ltd | Pharmaceutical composition containing IVIG for use in treating lymphoma |
-
1994
- 1994-11-15 US US08/340,094 patent/US5562902A/en not_active Expired - Lifetime
-
1995
- 1995-03-09 CA CA002184269A patent/CA2184269A1/en not_active Abandoned
- 1995-03-09 NZ NZ282659A patent/NZ282659A/en not_active IP Right Cessation
- 1995-03-09 JP JP52408195A patent/JP4004062B2/ja not_active Expired - Fee Related
- 1995-03-09 BR BR9507067A patent/BR9507067A/pt not_active Application Discontinuation
- 1995-03-09 ES ES95912808T patent/ES2155519T3/es not_active Expired - Lifetime
- 1995-03-09 AT AT95912808T patent/ATE198711T1/de not_active IP Right Cessation
- 1995-03-09 DK DK95912808T patent/DK0750514T3/da active
- 1995-03-09 AU AU19848/95A patent/AU700751B2/en not_active Ceased
- 1995-03-09 PT PT95912808T patent/PT750514E/pt unknown
- 1995-03-09 KR KR1019960705054A patent/KR100352583B1/ko not_active IP Right Cessation
- 1995-03-09 DE DE69519924T patent/DE69519924T2/de not_active Expired - Lifetime
- 1995-03-09 CN CN95192080A patent/CN1089007C/zh not_active Expired - Fee Related
- 1995-03-09 WO PCT/US1995/002910 patent/WO1995024927A1/en active IP Right Grant
- 1995-03-09 EP EP95912808A patent/EP0750514B1/en not_active Expired - Lifetime
- 1995-03-12 IL IL11296395A patent/IL112963A/xx not_active IP Right Cessation
- 1995-03-13 TW TW084102356A patent/TW418091B/zh not_active IP Right Cessation
- 1995-06-07 US US08/487,803 patent/US5965130A/en not_active Expired - Fee Related
-
1996
- 1996-09-12 FI FI963598A patent/FI114011B/fi not_active IP Right Cessation
-
1998
- 1998-12-22 HK HK98114792A patent/HK1014493A1/xx not_active IP Right Cessation
-
2001
- 2001-04-17 GR GR20010400610T patent/GR3035758T3/el not_active IP Right Cessation
-
2007
- 2007-02-08 JP JP2007029855A patent/JP2007119493A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US5965130A (en) | 1999-10-12 |
CN1089007C (zh) | 2002-08-14 |
CA2184269A1 (en) | 1995-09-21 |
DE69519924D1 (de) | 2001-02-22 |
GR3035758T3 (en) | 2001-07-31 |
HK1014493A1 (en) | 1999-09-30 |
JPH09512791A (ja) | 1997-12-22 |
FI963598A0 (fi) | 1996-09-12 |
DE69519924T2 (de) | 2001-08-23 |
DK0750514T3 (da) | 2001-05-21 |
EP0750514A1 (en) | 1997-01-02 |
BR9507067A (pt) | 1997-09-30 |
IL112963A (en) | 2000-02-17 |
FI963598A (fi) | 1996-09-12 |
NZ282659A (en) | 1998-06-26 |
CN1148343A (zh) | 1997-04-23 |
JP2007119493A (ja) | 2007-05-17 |
EP0750514B1 (en) | 2001-01-17 |
KR100352583B1 (ko) | 2002-12-26 |
JP4004062B2 (ja) | 2007-11-07 |
ATE198711T1 (de) | 2001-02-15 |
TW418091B (en) | 2001-01-11 |
ES2155519T3 (es) | 2001-05-16 |
PT750514E (pt) | 2001-06-29 |
US5562902A (en) | 1996-10-08 |
AU1984895A (en) | 1995-10-03 |
AU700751B2 (en) | 1999-01-14 |
WO1995024927A1 (en) | 1995-09-21 |
IL112963A0 (en) | 1995-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Greiner et al. | Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo | |
JP2007119493A (ja) | γグロブリンの投与によるガン性疾患を処置するための免疫療法 | |
Folli et al. | Tumor‐necrosis factor can enhance radio‐antibody uptake in human colon carcinoma xenografts by increasing vascular permeability | |
JPS60502104A (ja) | α―インターフェロンに対する抗体と複合されたα―インターフェロン治療製剤 | |
O'Donnell et al. | Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium‐DOTA‐peptide‐ChL6 | |
WO1992007466A1 (en) | Synergistic therapy with combinations of anti-tumor antibodies and biologically active agents | |
TWI818120B (zh) | 藉由免疫檢查點阻礙藥與folfirinox療法之併用的癌症治療 | |
EP1220687B1 (en) | Administration of gamma globulins to treat lymphoma | |
US20080050390A1 (en) | Administration of gamma globulins to treat metastatic melanoma | |
CA1340898C (en) | Monoclonal antibodies against lymphoma-associated antigens, hybrid cell lines producing these antibodies, and use therefore | |
JPH07500565A (ja) | 免疫抑制ムチンを生成する腺がんの能動的特異免疫療法 | |
NO321038B1 (no) | Immunoterapeutisk behandlingsmetode for kreftsykdommer ved tilforsel av gammaglobuliner | |
CN110151987B (zh) | 对称IgG及其组合物在制备治疗及预防肿瘤的药物中的用途 | |
WO2024140833A1 (zh) | 药物组合及其应用 | |
WO2023061472A1 (zh) | 抗her2抗体药物偶联物和酪氨酸激酶抑制剂联合在制备治疗肿瘤的药物中的用途 | |
US20070166313A1 (en) | Administration of gamma globulins to treat cancer | |
AU650080B2 (en) | Synergistic therapy with combinations of anti-tumor antibodies and biologically active agents | |
Yu et al. | Immunotherapy of xenografted human bladder cancer in nude mice using monoclonal antibody | |
TW202200191A (zh) | 包含含有il-2蛋白與cd80蛋白之融合蛋白及抗癌藥物的用於治療癌症的藥學組成物 | |
JP2544146B2 (ja) | 上咽頭癌治療剤 | |
JPH01197442A (ja) | 抗腫瘍剤 | |
WO2000020022A1 (en) | Methods for the treatment of cancer using cytokines in combination with low level doses of chemotherapy and/or radiotherapy | |
WO1996040176A1 (en) | Therapeutic uses of monoclonal antibody ta99 in combination with interleukin-2 and/or lymphokine activated killer cells | |
KR20040091623A (ko) | 암 치료 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or assigment of application |
Owner name: ARP BIOMED LTD. |
|
MM | Patent lapsed |